Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Channing Paller MD

Channing J Paller MD

Assistant Professor of Oncology, Johns Hopkins University SOM and Sibley Memorial Hospital, Washington, DC

Channing J. Paller, M.D, is Assistant Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University where she specializes in the development of new prostate cancer therapeutics. She serves as director of the Specimen Accessioning Core at Hopkins Sibley Memorial Hospital and serves on the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee. Dr. Paller earned her M.D. at Harvard Medical School, and completed her medical residency and oncology fellowship at the Johns Hopkins Hospital.

Recent Contributions to PracticeUpdate:

  1. Severe Neutropenia During Cabazitaxel Treatment Is Associated With Survival Benefit in Men With Metastatic Castration-Resistant Prostate Cancer
  2. Primary Androgen-Deprivation Therapy Not Effective in Localized Prostate Cancer

Recently Updated